Plasma concentration of amrubicinol in plateau phase in patients treated for 3 days with amrubicin is correlated with hematological toxicities

Plasma concentration of amrubicinol in plateau phase in patients treated for 3 days with amrubicin is correlated with hematological toxicities
复制标题

使用氨柔比星治疗 3 天的患者中,氨柔比星的平台期血浆浓度与血液学毒性相关

DOI:
--
复制
发表时间:
2009
期刊:
Anti-Cancer Drugs (In press)
影响因子:
--
通讯作者:
et.al.
et.al.
中科院分区:
--
文献类型:
--
作者:
Kimura T;et.al.

文献摘要

相似文献